OnCusp Therapeutics’ Oversubscribed US$100 Million Series A Financing Round

Sidley Austin represented OnCusp Therapeutics, Inc. in the transaction.OnCusp Therapeutics, Inc., a biopharmaceutical company, announced it has raised US$100 million (more than RMB700 million) Series A financing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here